Publications
5674 Results
- Journal / Conference
- American Society of Human Genetics (Oct 16-20, San Diego, CA), accepted, poster #2614T
- Year
- 2018
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000C
Replicated association of CYP4F2 variant with change in plasma vitamin E level after supplementation
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster
- Year
- 2018
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1202
Association between Body Mass Index (BMI) and Response to Duloxetine for Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms (AIMSS)
- Journal / Conference
- International Symposium on Hodgkin Lymphoma (October 27-29, 2018, Cologne, Germany), abst #T019 (0026), oral
- Year
- 2018
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Potential impact of consolidation radiation therapy for advanced Hodgkin Lymphoma: a secondary modeling analysis of SWOG S0816
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster, P4-08-06
- Year
- 2018
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9313
Impact of molecular subtypes on long term outcomes in triple negative breast cancer (TNBC) patients treated with adjuvant AC chemotherapy on SWOG S9313
- Journal / Conference
- Blood 132:1593; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
- Year
- 2018
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1106
5-Year Follow Up Results of S1106: A Randomized Phase II Us Intergroup Study of R-Hcvad Vs. R-Bendamustine Followed by Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma
- Journal / Conference
- Blood 132:919; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
- Year
- 2018
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Subclonal Mutations of TP53 are common in untreated follicular lymphoma and are predictive of a shortened PFS when CHOP is combined 131-Iodine Tositumomab but not with rituximab: an analysis of SWOG S0016 clinical trial
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster, P1-17-03
- Year
- 2018
- Research Committee(s)
- Breast
- Study Number(s)
- S0307
Statin use, site of recurrence, and survival among post-menopausal women taking bisphosphonates as adjuvant therapy for primary breast cancer (SWOG S0307)
- Journal / Conference
- Annals of Oncology, Vol 29, Issue suppl_8, 1; ESMO 2018 Congress (October 19-23, Munich, Germany), poster
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1216
Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel
- Journal / Conference
- Blood 132:3978; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
- Year
- 2018
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333
2nd Cycle Remission Achievement with 7+3 is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials
- Journal / Conference
- Blood 132:929; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
- Year
- 2018
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816